| answer text |
<p>The UK has played a leading role in supporting global access to safe and effective
COVID-19 vaccines. The UK is among the largest donors to COVAX, which aims to provide
vaccine doses for up to 30% of the population in low and middle-income countries by
early 2022. The UK's investment in the research and development of the Oxford/AstraZeneca
vaccine has also been a key contribution to the global vaccination effort. So far,
over 500 million doses of the vaccine have been distributed worldwide at non-profit
prices, with two-thirds going to lower and middle- income countries.</p><p>The UK
is proud that our G7 Presidency secured agreement from leaders to commit to sharing
at least 870 million doses over the next year, including a commitment from the UK
to share 100 million doses. In addition, we are working closely with G7 and international
partners to mobilise international financing, increase vaccine supply, and support
in-country delivery, including community mobilisation, and building vaccine confidence.</p>
|
|
